Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_134_treasury_shares_espi.pdfNotification for sale of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 134 / 2026
Date of issue: 2026-05-11
Short name of the issuer
SOPHARMA AD
Subject
Notification for sale of treasury shares
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, May 11, 2026 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on May 08, 2026 the Company sold 23 000 (twenty-three thousand) treasury shares representing 0.004% of the share capital of the Company, at a total value of EUR 42 450.00 on the Bulgarian Stock Exchange, the average price per share was EUR 1.86.
The total number of treasury shares after this transaction is 10 155 000 representing 1.88% of the share capital of the Company.
Annexes
File Description
Current report_134_treasury_shares_espi.pdf
Current report_134_treasury_shares_espi.pdf		 Notification for sale of treasury shares

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-05-11 Ognian Ivanov Donev Executive Director
20260511_082955_0497210307_Current_report_134_treasury_shares_espi.pdf

Pobierz